These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13863455)

  • 41. THE EFFECT OF ADRENERGIC NEURONE BLOCKING AGENTS ON THE RELEASE AND UPTAKE OF CATECHOLAMINES BY THE RAT HEART.
    BHAGAT B
    Arch Int Pharmacodyn Ther; 1963 Nov; 146():231-7. PubMed ID: 14077712
    [No Abstract]   [Full Text] [Related]  

  • 42. Catecholamine depletion and adrenergic neurone blockade: studies with debrisoquine.
    Robertson MI; Abbs ET
    J Neurochem; 1971 Oct; 18(10):1999-2001. PubMed ID: 4399089
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of guanethidine and bretylium on the liberation of pyrocatecholamines].
    PHILIPPU A; SCHUEMANN HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962; 243():26-35. PubMed ID: 14486205
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of adrenergic drugs on venous blood outflow from the rat brain].
    Gorshkova VK; Saratikov AS; Usov LA
    Biull Eksp Biol Med; 1971 Jul; 72(7):58-60. PubMed ID: 5565499
    [No Abstract]   [Full Text] [Related]  

  • 45. [Age-related characteristics of the effect of adrenomimetics on the noradrenaline and adrenaline content in the myocardium of the rat].
    Viktorov AP
    Farmakol Toksikol; 1984; 47(3):43-6. PubMed ID: 6734806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of sympathetic and parasympathetic drugs on the electromyograms of the dog's stomach].
    TAKASE S
    Tohoku Igaku Zasshi; 1961 Sep; 64():308-30. PubMed ID: 13919152
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanism of action of guanethidine.
    KADZIELAWA K
    Br J Pharmacol Chemother; 1962 Aug; 19(1):74-84. PubMed ID: 14453004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interaction of dl-mandelamidine (Olimidine) with some antihypertensive drugs expressed in the blood pressure of conscious rats].
    Ozawa H; Hironaka Y
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):331-40. PubMed ID: 9340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The initial pressor actions of bretylium tosylate and guanethidine sulfate and their relation to release of catecholamines.
    GILLIS CN; NASH CW
    J Pharmacol Exp Ther; 1961 Oct; 134():1-7. PubMed ID: 13898659
    [No Abstract]   [Full Text] [Related]  

  • 50. Modern views on pharmacology. 8. Antagonists of adrenergic neurone activity.
    Crossland J
    Practitioner; 1971 Aug; 207(238):244-50. PubMed ID: 4105249
    [No Abstract]   [Full Text] [Related]  

  • 51. INOTROPIC AND CHRONOTROPIC EFFECTS OF DICHLOROISOPROTERENOL ON RAT ATRIA.
    VOGIN EE; DHALLA NS
    J Pharmacol Exp Ther; 1965 Jan; 147():65-9. PubMed ID: 14255163
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of adrenergic and adrenolytic drugs on the degranulation of pancreatic beta cells due to tolbutamide in rats. 1].
    Tessitore V; Costa V; Rigardo S
    Biol Lat; 1968; 21(1):19-27. PubMed ID: 4981150
    [No Abstract]   [Full Text] [Related]  

  • 53. [Myocardial reaction to adrenergic drugs during the early periods of development (review of the literature)].
    Viktorov AP
    Farmakol Toksikol; 1977; 40(2):239-45. PubMed ID: 15864
    [No Abstract]   [Full Text] [Related]  

  • 54. Supersensitivity of salivary glands following treatment with bretylium or guanethidine.
    EMMELIN N; ENGSTROM J
    Br J Pharmacol Chemother; 1961 Jun; 16(3):315-9. PubMed ID: 13726638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of the opticalisomer of N-1-(4'-nitrophenyl)-2-isopropylethanolamine (INPEA) on the uptake of 3H-norepinephrine by the cardiac muscle of the rat in vitro.
    Janiec W; ChruĊ›ciel TL
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):255-63. PubMed ID: 4390663
    [No Abstract]   [Full Text] [Related]  

  • 56. THE ADRENERGIC-NEURONE BLOCKING ACTION OF SOME COUMARAN COMPOUNDS.
    FIELDEN R; ROE AM; WILLEY GL
    Br J Pharmacol Chemother; 1964 Dec; 23(3):486-507. PubMed ID: 14256809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastric secretory responses to drugs affecting adrenergic mechanisms in rats.
    Bass P; Patterson MA
    J Pharmacol Exp Ther; 1967 Apr; 156(1):142-9. PubMed ID: 4381554
    [No Abstract]   [Full Text] [Related]  

  • 58. Fate of norepinephrine in sympathetic nerons and by cardiovascular drugs.
    Axelrod J; Wurtman RJ
    N Y State J Med; 1968 Jan; 68(2):252-6. PubMed ID: 4383958
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the pharmacology of 2-(2,6-dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazine (Bayer 1470), a substance inhibitory for adrenergic and cholinergic neurons].
    Kroneberg G; Oberdorf A; Hoffmeister F; Wirth W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):257-80. PubMed ID: 4233002
    [No Abstract]   [Full Text] [Related]  

  • 60. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.